Hepatitis C knowledge among new injection drug users

Drugs: Education, Prevention and Policy

Volumn 17, Issue 6, 2010, Pages 821-834

  Jost, John J ^a   Goldsamt, Lloyd A ^a   Harocopos, Alex ^a   Kobrak, Paul ^a   Clatts, Michael C ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77958612732     PISSN: 09687637     EISSN: 14653370     Source Type: Journal    
DOI: 10.3109/09687630902858948     Document Type: Article

References (54)

1. Alter, M. J., Kruszon-Moran, D., Nianan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., et al.(1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.New England Journal of Medicine, 341, 556-562.
2. Bourgois, P. (1998). The moral economies of homeless heroin addicts: Confronting ethnography,HIV risk and everyday violence in San Francisco shooting encampments. Substance Use and Misuse, 33, 2323-2351.
3. Carey, J., Perlman, D. C., Friedmann, P., Kaplan, W. M., Nugent, A., Deutscher, M., et al.(2005). Knowledge of hepatitis among active drug injectors at a syringe exchange program.Journal of Substance Abuse Treatment, 29, 47-53.
4. Centers for Disease Control, and Prevention (2006). Viral hepatitis C fact sheet. Atlanta: Centers forDisease Control and Prevention.
5. C. Everett Koop Institute (2009). Hepatitis C: An epidemic for everyone. Retrieved February 10,2009, from http://www.epidemic.org/theFacts/theEpidemic
6. Connors, M. M. (1994). Stories of pain and the problem of AIDS prevention: Injection drugwithdrawal and its effect on risk behavior. Medical Anthropology Quarterly, 8, 47-68.
7. Copeland, L. (2004). The drug user's identity and how it relates to being hepatitis C antibodypositive: A qualitative study. Drugs: Education, Prevention and Policy, 11, 129-147.
8. Crofts, N., Jolley, D., van Beek, I., & Wodak, A. (1997). Epidemiology of hepatitis C virus infectionamong injecting drug users in Australia. Journal of Epidemiology and Community Health, 51,692-697. (Pubitemid 28014247)
9. Danta, M., van de Laar, T., Brown, D., Pybus, O., Bhagani, S., Vogel, M. et al. (2007, July).Evidence of international transmission of HCV in pan-European HIV-positive men who have sex withmen (MSM). Paper presented at 4th International AIDS Society Conference, Sidney, Australia.
10. Davis, M., & Rhodes, T. (2003). Beyond prevention? Injecting drug user narratives about hepatitisC. International Journal of Drug Policy, 15, 123-131.
11. Davis, M., Rhodes, T., & Martin, A. (2004). Preventing hepatitis C: 'Common sense', 'the bug'and other perspectives from the risk narratives of people who inject drugs. Social Science &Medicine, 59, 1807-1818.
12. Des Jarlais, D. C., & Friedman, S. R. (1989). AIDS and IV drug use. Science, 245, 578-579.
13. Des Jarlais, D. C., & Friedman, S. R. (2003). Variability in the incidence of humanimmunodeficiency virus, hepatitis B virus and hepatitis C virus infection among younginjection drug users in New York City. American Journal of Epidemiology, 157, 467-471.
14. Evans, M., Stotts, A. L., Graham, S., Schmitz, J., & Grabowski, J. (2004). Hepatitis C knowledgeassessment and counseling within the context of substance abuse treatment. Addictive Disorders& Their Treatment, 3, 18-26.
15. Fraser, S. (2004). 'It's your life!': injecting drug users, individual responsibility and hepatitis Cprevention. Health: An interdisciplinary Journal for the Social Study of Health, Illness and Medicine,8, 199-221.
16. Fraser, S., & Treloar, C. (2006). 'Spoiled identity' in hepatitis C infection: The binary logic ofdespair. Critical Public Health, 16, 99-110.
17. Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., et al. (2001).Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology, 34,809-816.
18. Galvin, R. (2002). Disturbing notions of chronic illness and individual responsibility: Towards agenealogy of morals. Health: An interdisciplinary Journal for the Social Study of Health, Illness andMedicine, 6, 107-137.
19. Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., & Vlahov, D.(1998). Prevalence and incidence of hepatitis C virus infection among young adult injectiondrug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18,S11-19.
20. Ghosn, J., Deveau, C., Goujard, C., Saichi, N., Galimand, J., Nagy, Z., et al. (2006). Increase inhepatitis C virus incidence in HIV-1-infected patients followed up since primary infection.Sexually Transmitted Infections, 82, 458-460.
21. Giraudon, I., Ruf, M., Maguire, H., Charlett, A., Ncube, F., Turner, J., et al. (2008). Increase indiagnosed newly acquired hepatitis C in HIV-positive men who have sex with men acrossLondon and Brighton, 2002-2006: Is this an outbreak. Sexually Transmitted Infections, 84,111-115.
22. Grebely, J., Genoway, K., Raffa, J. D., Dhadwal, G., Rajan, T., Showler, G., et al. (2008). Barriersassociated with the treatment of hepatitis C virus infection among illicit drug users. Drug andalcohol Dependence, 93, 141-147.
23. Hagan, H., Thiede, H., & Des Jarlais, D. C. (2004). Hepatitis C virus infection among injectiondrug users: Survival analysis of time to seroconversion. Epidemiology, 15, 543-549.
24. Hagan, H., Thiede, H., Weiss, N. S., Hopkins, S. G., Duchin, J. S., & Alexander, E. R. (2001).Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of PublicHealth, 91, 42-46.
25. Hahn, J. A., Page-Shafer, K., Lum, P. J., Bourgois, P., Stein, E., Evans, J. L., et al. (2002).Hepatitis C seroconversion among young injection drug users: Relationships and risks. Journalof Infectious Diseases, 186, 1558-1564.
26. Hahn, J. A., Page-Shafer, K., Lum, P. J., Ochoa, K., & Moss, A. R. (2001). Hepatitis C infectionand needle exchange use among young drug injection drug users in San Francisco. Hepatology,34, 180-187.
27. Heimer, R., Clair, S., Grau, L. E., Bluthenhal, R. N., Marshall, P. A., & Singer, M. (2002).Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug usersin three US cities. Addiction, 97, 1277-1287.
28. Koester, S., Glanz, J., & Baro, A. (2005). Drug sharing among heroin networks: Implications forHIV and hepatitis B and C prevention. AIDS and Behavior, 9, 27-39.
29. Kwiatkowski, C. F., Fortuin Corsi, K., & Booth, R. E. (2002). The association between knowledgeof hepatitis C virus status and risk behaviors in injection drug users. Addiction, 97, 1289-1294.
30. Limburg, W. (2004). National history, treatment and prevention of hepatitis C in injecting drugusers. In J. C. Jager, W. Limburg, M. Kretzschmar, M. J. Postma, & L. Wiessing (Eds.),Hepatitis C and injecting drug use: Impact, costs and policy options (pp. 21-40). Lisbon: EuropeanMonitoring Centre for Drugs And Drug Addiction.
31. Maher, L., Jalalduin, B., Chant, K. G., Jayasuriya, R., Sladden, T., Kaldor, J. M., et al. (2006).Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.Addiction, 101, 1499-1508.
32. Mansson, A. S., Moestrup, T., Nordenfelt, E., & Widell, A. (2000). Continued transmission ofhepatitis B and C viruses, but no transmission of human immunodeficiency virus amongintravenous drug users participating in a syringe/needle exchange program. ScandinavianJournal of Infectious Disease, 32, 253-258.
33. Matthews, G. V., Hellard, M., Kaldor, J., Lloyd, A., & Dore, G. J. (2007). Further evidence ofHCV sexual transmission among HIV-positive men who sex with men: Response to Danta et al.AIDS, 21, 2112-2113.
34. Pohl, A., Behling, C., Oliver, D., Kilani, M., Monson, P., & Hasssanein, T. (2002).Recommendations from the National Institutes of Health consensus development conferencestatement: Management of hepatitis C. Hepatology, 36, 1039.
35. Rhodes, T., & Cusick, L. (2002). Accounting for unprotected sex: stories of agency andacceptability. Social Science and Medicine, 55, 211-266.
36. Rhodes, T., Davis, D., & Judd, A. (2004). Hepatitis C and its risk management among druginjectors in London: Renewing harm reduction in the context of uncertainty. Addiction, 99,621-633.
37. Rhodes, T., Zihic, B., Prodanovic, A., Kuneski, E., & Bernays, S. (2008). Hygiene and uncertaintyin qualitative accounts of hepatitis C transmission among drug injectors in Siberia. Social Science& Medicine, 66, 1437-1447.
38. Rosenblum, A., Nuttbrock, L., McQuistion, H., Magura, S., & Joseph, H. (2001). Hepatitis C andsubstance use in a sample of homeless people in New York City. Journal of Addictive Diseases,20, 15-25.
39. Roy, K., Hay, G., Andragetti, R., Taylor, A., Goldberg, D., & Wiessing, L. (2002). Monitoringhepatitis C infection among injecting drug user in the European Union: A review of theliterature. Epidemiology and Infection, 129, 577-585.
40. Roy, E., Nonn, E., Haley, N., & Cox, J. (2007). Hepatitis C meanings and preventive strategiesamong street-involved young injection drug users in Montreal. International Journal of DrugPolicy, 18, 397-405.
41. Smyth, B. P., McMahon, J., O'Connor, J. J., & Ryan, J. (1999). Knowledge regardingHepatitis C among injecting drug users. Drugs: Education, Prevention and Policy, 6, 257-264.
42. Stark, K., Muller, R., Bienzle, U., & Guggenmoos-Holzmann, I. (1996). Frontloading: A risk factorfor HIV and hepatitis C virus infection among injecting drug users in Berlin. AIDS, 10,311-317.
43. Stein, M. D., Maksad, J., & Clarke, J. (2001). Hepatitis C disease among injection drug users:Knowledge, perceived risk and willingness to receive treatment. Drug and Alcohol Dependence,61, 211-215.
44. Strauss, A. L. (1987). Qualitative analysis for social scientists. Cambridge, UK: Cambridge University Press.
45. Strauss, A. L., & Corbin, J. (1990). Basics of qualitative research: Grounded theory procedures andtechniques. Newbury Park, CA: Sage.
46. Tahan, V., Karaca, C., Yildirim, B., Bozbas, A., Ozaras, R., Demir, K., et al. (2005).Sexual transmission of HCV between spouses. American Journal of Gastroenterology, 100,821-824.
47. Taylor, A., Goldberg, D., Hutchinson, S., Cameron, S., Gore, S., McMenamin, J., et al.(2000). Prevalence of hepatitis C virus infection among injecting drug users in Glasgow1990-1996: Are current harm reduction strategies working? Journal of Infection, 40,176-183.
48. Thorpe, L. E., Ouellet, L. J., Levy, J. R., Williams, I. T., & Monterroso, E. R. (2000). HepatitisC virus infection: Prevalence, risk factors, and prevention opportunities among youngdrug users in Chicago, 1997-1999. Journal of Infectious Diseases, 182, 1588-1594.
49. Tortu, S., McMahon, J. M., Pouget, E. R., & Hamid, R. (2004). Sharing of noninjection drug-useimplements as a risk factor for hepatitis C. Substance Use and Misuse, 39, 211-224.
50. Treloar, C., & Abelson, J. (2005). Information exchange among injecting drug users: A role for anexpanded peer education workforce. International Journal of Drug Policy, 16, 46-53.
51. Vandelli, C., Renzo, F., Romano, L., Tisminetzky, S., De Palma, M., Stroffolini, T., et al. (2004).Lack of evidence of sexual transmission of hepatitis C among monogamous couples: Results ofa 10-year prospective follow-up study. American Journal of Gastroenterology, 99, 855-859.
52. Villano, S. A., Nelson, K. E., Vlahov, D., Purcell, R. D., Saah, A. J., & Thomas, D. L. (1997).Hepatitis A among homosexual men and injection drug users: More evidence for vaccination.Clinical Infectious Diseases, 25, 726-728.
53. Wozniak, L., Prakash, M., Taylor, M., & Wild, T.C. (2007). Everybody's got it, but. . . : situationaland strategic participation in normalized HCV discourse among injection drug users inEdmonton, Canada. International Journal of Drug Policy, 18, 388-396.
54. Wright, N., Tompkins, C., & Jones, L. (2005). Exploring risk perception and behavior of homelessinjecting drug users diagnosed with hepatitis C. Health and Social Care in the Community, 13,75-83.